Chief Business Officer
John Krayacich brings to Vaxxinity over 25 years of experience in a variety of business development, project management and commercial roles. Prior to joining Vaxxinity, John was Senior Vice- President, Global Business Development at LEO Pharma for the past three and half years, responsible for in-licensing, out-licensing and M&A for research, development, and commercial transactions. Priorto LEO, John was with Novartis in a variety of roles including, leading the US business development team, leading the Neuroscience Project Management team, and leading the Neuroscience Global Search and Evaluation. Prior to Novartis, John was CEO of two neuroscience biotech companies; Marinus Pharmaceuticals and Ambrose Pharmaceuticals, as well as, working for Pfizer in a number of commercial roles, including leading the Neurology and Atherosclerosis business units. John received his Bachelor of Science degree and Master of Science degree in Physiology from the University of Western Ontario, and his Master’s in business administration from the Ivey Business School at the University of Western Ontario.